March 1, 2024 · Form 4 insider transaction
Kelly James Patrick bought 176,000 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 25 days after the transaction.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.; One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.